THE PRECLINICAL STUDIES OF LAPATINIB IN PREVENTION OF HER2-OVEREXPRESSING EARLY-STATE BREAST DISEASE FROM PROGRESSION TO CANCER
$125,526FY2010Department of the ArmyDOD
The Univeristy Of Texas M.D. Anderson Cancer Center
The Univeristy Of Texas M.D. Anderson Cancer Center